Vector Science & Therapeutics issues corrected release on Verlytix launch details

• Vector Science & Therapeutics issued a corrected version of its Aug. 18 release on Verlytix’s launch and relationship to LyoGenesis Manufacturing.
• The amendment added detail that Verlytix’s analytical platform will support peptide testing for Vector’s peptide portfolio alongside its existing pharma testing business.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vector Science and Therapeutics Corp. published the original content used to generate this news brief via CNW (Ref. ID: 202608190755CANADANWCANADAPR_C0793) on August 19, 2026, and is solely responsible for the information contained therein.